α-Synuclein Aggregates and Parkinson's disease DOI Creative Commons

Isadora Cucolo Oliveira,

Tárik Abdalla dos Santos,

Ian Vilas Boas Covizzi

et al.

Seven Editora eBooks, Journal Year: 2024, Volume and Issue: unknown

Published: March 22, 2024

Parkinson's disease (PD) is characterized by the progressive degeneration of dopaminergic neurons substantia nigra, leading to motor changes that progress tremors, rigidity and bradykinesia with postural instability.

Language: Английский

Focus on senescence: Clinical significance and practical applications DOI Creative Commons
Virginia Boccardi, Miranda E. Orr, Maria Cristina Polidori

et al.

Journal of Internal Medicine, Journal Year: 2024, Volume and Issue: 295(5), P. 599 - 619

Published: March 6, 2024

Abstract The older population is increasing worldwide, and life expectancy continuously rising, predominantly thanks to medical technological progress. Healthspan refers the number of years an individual can live in good health. From a gerontological viewpoint, mission extend spent health, promoting well‐being minimizing impact aging‐related diseases slow aging process. Biologically, malleable process characterized by intra‐ inter‐individual heterogeneous dynamic balance between accumulating damage repair mechanisms. Cellular senescence key component this process, with senescent cells different tissues organs, leading age‐related disease susceptibility over time. Removing from body or slowing down burden rate has been proposed as efficient way reduce age‐dependent deterioration. In animal models, senotherapeutic molecules lifespan either senolytic senomorphic activity. Much research shows that dietary physical activity‐driven lifestyle interventions protect against senescence. This narrative review aims summarize current knowledge on targeting risk models their translational potential for humans. We focused studies have examined role senotherapeutics modifying burdens. concludes general discussion mechanisms underlying unique trajectory its implications future research.

Language: Английский

Citations

18

Mitochondrial dysfunction in chronic neuroinflammatory diseases (Review) DOI Creative Commons
Pei Qin,

Ye Sun,

Liya Li

et al.

International Journal of Molecular Medicine, Journal Year: 2024, Volume and Issue: 53(5)

Published: April 2, 2024

Chronic neuroinflammation serves a key role in the onset and progression of neurodegenerative disorders. Mitochondria serve as central regulators neuroinflammation. In addition to providing energy cells, mitochondria also participate immunoinflammatory response disorders including Alzheimer's disease, Parkinson's multiple sclerosis epilepsy, by regulating processes such cell death inflammasome activation. Under inflammatory conditions, mitochondrial oxidative stress, epigenetics, dynamics calcium homeostasis imbalance may underlying regulatory mechanisms for these diseases. Therefore, investigating related dysfunction result therapeutic strategies against chronic neurodegeneration. The present review summarizes neuroinflammatory diseases current treatment approaches that target

Language: Английский

Citations

18

Type 2 Diabetes Mellitus Exacerbates Pathological Processes of Parkinson's Disease: Insights from Signaling Pathways Mediated by Insulin Receptors DOI Creative Commons
Shufen Liu, Tingting Liu, Jingwen Li

et al.

Neuroscience Bulletin, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 4, 2025

Language: Английский

Citations

2

PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson’s disease in rats DOI Creative Commons

Heba A. Farid,

Rabab H. Sayed,

Marwa El-Sayed El-Shamarka

et al.

Inflammopharmacology, Journal Year: 2023, Volume and Issue: 32(2), P. 1421 - 1437

Published: Aug. 4, 2023

Abstract Parkinson’s disease (PD) is the second most common progressive age-related neurodegenerative disorder. Paramount evidence shed light on role of PI3K/AKT signaling activation in treatment disorders. can be activated via cAMP-dependent pathways achieved by phosphodiesterase 4 (PDE4) inhibition. Roflumilast a well-known PDE4 inhibitor that currently used chronic obstructive pulmonary disease. Furthermore, roflumilast has been proposed as favorable candidate for neurological The current study aimed to unravel neuroprotective rotenone model PD rats. Ninety male rats were allocated into six groups follows: control, (1.5 mg/kg/48 h, s.c.), L-dopa (22.5 mg/kg, p.o), and (0.2, 0.4 or 0.8 p.o). All treatments administrated 21 days 1 h after injection. Rats treated with showed an improvement motor activity coordination well preservation dopaminergic neurons striatum. Moreover, increased cAMP level axis stimulation CREB/BDNF/TrkB SIRT1/PTP1B/IGF1 cascades. also caused upsurge mTOR Nrf2, halted GSK-3β NF-ĸB, suppressed FoxO1 caspase-3. Our revealed exerted effects rotenone-induced neurotoxicity These mediated crosstalk between which activates trajectory. Therefore, inhibition likely offer reliable persuasive avenue curing activation. Graphical

Language: Английский

Citations

24

Potential use of antioxidants for the treatment of chronic inflammatory diseases DOI Creative Commons

Alexander V. Blagov,

Volha I. Summerhill, Vasily N. Sukhorukov

et al.

Frontiers in Pharmacology, Journal Year: 2024, Volume and Issue: 15

Published: May 16, 2024

The excessive production of various reactive oxidant species over endogenous antioxidant defense mechanisms leads to the development a state oxidative stress, with serious biological consequences. consequences stress depend on balance between generation and include damage biomolecules, disruption signal transduction, mutation, cell apoptosis. Accumulating evidence suggests that is involved in physiopathology debilitating illnesses associated chronic inflammation, including cardiovascular diseases, diabetes, cancer, or neurodegenerative processes, need continuous pharmacological treatment. Oxidative inflammation are tightly linked pathophysiological one which can be simply promoted by another. Although, many trials have been unsuccessful (some showed either no effect even harmful effects) human patients as preventive curative measure, targeting remains an interesting therapeutic approach for new agents design novel anti-inflammatory drugs reliable safety profile. In this regard, several natural compounds were explored potential options treatment inflammatory diseases. Several metalloenzymes, such superoxide dismutase, catalase, glutathione peroxidase, among essential enzymes maintain low nanomolar physiological concentrations (O 2 •−) hydrogen peroxide (H O ), major redox signaling molecules, thus play important roles alteration homeostasis. These become striking source motivation catalytic enhance action these under pathological conditions related inflammation. This review focused representatives synthetic antioxidants drug candidates

Language: Английский

Citations

16

Oxidative Stress and Neurodegeneration: Insights and Therapeutic Strategies for Parkinson’s Disease DOI Creative Commons

Erjola Bej,

Patrizia Cesare,

Anna Rita Volpe

et al.

Neurology International, Journal Year: 2024, Volume and Issue: 16(3), P. 502 - 517

Published: April 29, 2024

Parkinson’s disease (PD) is a progressive neurodegenerative condition marked by the gradual deterioration of dopaminergic neurons in substantia nigra. Oxidative stress has been identified as key player development PD recent studies. In first part, we discuss sources oxidative PD, including mitochondrial dysfunction, dopamine metabolism, and neuroinflammation. This paper delves into possibility mitigating potential treatment approach for PD. addition, examine hurdles antioxidant therapy, challenge delivering antioxidants to brain requirement biomarkers track patients. However, even if therapy holds promise, further investigation needed determine its efficacy safety treatment.

Language: Английский

Citations

14

Single nanozyme-based colorimetric biosensor for dopamine with enhanced selectivity via reactivity of oxidation intermediates DOI

Caixia Zhu,

Qing Hong,

Kaiyuan Wang

et al.

Chinese Chemical Letters, Journal Year: 2024, Volume and Issue: 35(10), P. 109560 - 109560

Published: Feb. 1, 2024

Language: Английский

Citations

10

Neuroprotective Effects of Olive Oil: A Comprehensive Review of Antioxidant Properties DOI Creative Commons
Marta Gonçalves, Nuno Vale, Paula Silva

et al.

Antioxidants, Journal Year: 2024, Volume and Issue: 13(7), P. 762 - 762

Published: June 24, 2024

Neurodegenerative diseases are a significant challenge to global healthcare, and oxidative stress plays crucial role in their development. This paper presents comprehensive analysis of the neuroprotective potential olive oil, with primary focus on its antioxidant properties. The chemical composition including key antioxidants, such as oleuropein, hydroxytyrosol, oleocanthal, is systematically examined. mechanisms by which these compounds provide neuroprotection, counteracting damage modulating pathways, explored. efficacy oil evaluated synthesizing findings from various sources, vitro studies, animal models, clinical trials. integration into dietary patterns, particularly Mediterranean diet, broader implications neurodegenerative disease prevention also discussed. challenges translating preclinical applications acknowledged future research directions proposed better understand mitigating risk conditions. review highlights not only component, but promising candidate preventive neurology, advocating for further investigation context diseases.

Language: Английский

Citations

10

Combating Parkinson’s Disease with Plant-Derived Polyphenols: Targeting Oxidative Stress and Neuroinflammation DOI
Reem M. Gahtani,

Shoaib Shoaib,

Umme Hani

et al.

Neurochemistry International, Journal Year: 2024, Volume and Issue: 178, P. 105798 - 105798

Published: June 29, 2024

Language: Английский

Citations

10

PET brain imaging in neurological disorders DOI
Lijun Xie,

Jihua Zhao,

Ye Li

et al.

Physics of Life Reviews, Journal Year: 2024, Volume and Issue: 49, P. 100 - 111

Published: March 24, 2024

Language: Английский

Citations

8